Eli Lilly and Company Overview

Company: Eli Lilly and Company
CEO: Mr. David A. Ricks
Founded: 1876
Symbol: LLY
Exchange: NYSE
Industry: Drug Manufacturers - General
Sector: Healthcare
About

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals; AbCellera Biologics; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics; Kumquat Biosciences; Entos Pharmaceuticals; and Foghorn Therapeutics Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Continue reading...
  • Ranking:

    1 among 2858 companies

  • Address:

    Lilly Corporate Center

  • City | State | Country:

    Indianapolis | IN | US

  • Phone:

    317 276 2000

  • Website:

Eli Lilly and Company (LLY)

  • Stock Price
  • Volume
750.78 +600.07 +398.16%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Net Income

Employees

Revenue by Segment

Revenue by Region

Executive Salary

Revenue per Employee

Profit per Employee

Income Statement

Operating Income

Research & Development

Tax Rate (%)

Assets & Liabilities | Cash Flow

Total Assets

Total Liabilities

Capital Expenditure

Ratios

Return on Equity (ROE)

Return on Assets (ROA)

Debt to Equity

Profitability

Gross Profit Margin (%)

Operating Income Margin (%)

Net Income Margin (%)

Earning Per Share

EBITDA

Free Cash Flow (FCF)

Valuation

Enterprise value

Enterprise value to Revenue

Enterprise value to EBITDA

Competitors’ Revenue

Frequently Asked Questions

When was Eli Lilly and Company founded?

Eli Lilly and Company was founded on 1876, which makes the company 149 years old.

Sign up for free to view

Who is the CEO of Eli Lilly and Company?

Mr. David A. Ricks is the CEO of Eli Lilly and Company.

What industry and sector is Eli Lilly and Company in?

Eli Lilly and Company operates in the Drug Manufacturers - General industry and the Healthcare sector.

What are Eli Lilly and Company's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000059478
  • SIC (Standard Industrial Classification): 2834
  • ISIN (International Securities Identification Number): US5324571083

Sign up for free to view

How many employees does Eli Lilly and Company have?

Eli Lilly and Company has 47,000 employees.

What is the revenue of Eli Lilly and Company?

In fiscal year 2024, Eli Lilly and Company generated a revenue of $45.04 Billion.

What is the net income of Eli Lilly and Company?

In fiscal year 2024, Eli Lilly and Company reported a net income of $10.59 Billion.

What is Eli Lilly and Company's biggest product segment?

Product is Eli Lilly and Company's biggest product segment, representing 90.47% of its total revenue.

When was Eli Lilly and Company listed on the stock exchange?

Eli Lilly and Company went public on Jun 1, 1972, through its Initial Public Offering (IPO), and it has been 53 years since then.

Sign up for free to view

What is the ticker symbol of Eli Lilly and Company, and where is it listed?

Eli Lilly and Company's ticker symbol is LLY, and the company is listed on the NYSE stock market exchange.

What is Eli Lilly and Company's current stock price?

Eli Lilly and Company's current stock price is $751.26 as of Jun 3, 2025.

What is Eli Lilly and Company's market capitalization?

As of , Eli Lilly and Company's market cap is .

What is Eli Lilly and Company's ranking in the world?

Ranked #1among 2,858 companies based on market cap.

Who are the top competitors of Eli Lilly and Company?

Competitors of Eli Lilly and Company include Johnson & Johnson, AbbVie and Merck & Co., and more.